{"affected":[{"defaultStatus":"unaffected","product":"Wingesfar","source":"CNA: ENISA","vendor":"CompuGroup Medical","versions":[{"lessThan":"2026.07a","status":"affected","version":"0","versionType":"custom"}]}],"cveId":"CVE-2026-118798","cwes":["CWE-532"],"description":"Multiple sensitive authentication data, including credentials, OAuth-related secrets, session information, and authentication artifacts, are exposed through application logs and persistent client-side storage, enabling unauthorized access and session compromise.","epss":null,"exploits":[],"kev":null,"metrics":[{"score":4.4,"severity":"medium","source":"CNA: ENISA","vector":"CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:U","version":"4.0"}],"modifiedAt":1794225928065,"publishedAt":1794225928065,"references":[{"source":"CNA: ENISA","tags":[],"url":"https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical"},{"source":"CNA: ENISA","tags":[],"url":"https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html"}],"remediation":[],"revision":"d7d7b82a536418267fbdf689c9924f45c99e44e06e91b94a6ed5563814538952","sources":[{"modifiedAt":1794225928065,"name":"CNA: ENISA","retrievedAt":1794229715326,"url":"https://www.cve.org/CVERecord?id=CVE-2026-118798"}],"ssvc":null,"status":"published","title":"Multiple sensitive authentication data exposed","updatedAt":1794229715326}